Literature DB >> 12727053

Lymphangioleiomyomatosis initially presenting with abdominal pain: a case report.

Hseuh-Chieh Lu1, Jane Wang, Yuk-Ming Tsang, Ming-Chieh Lin, Yiu-Wah Li.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare idiopathic disease characterized by hamartomatous smooth muscle proliferation of the lymph node, lymphatics, blood vessels as well as airways within the lungs, mediastinum and abdomen. It exclusively affects women during the reproductive period. Though extrapulmonary manifestations have been reported, the initial presentation of LAM as abdominal pain is extremely rare. To our knowledge, there are only three cases with LAM presenting first with abdominal symptoms so far [Chest 106 (1994) 267; Eur J Radiol 14 (1992) 192; Eur J Surg 157 (1991) 36]. We describe a case of LAM suffering from abdominal pain followed by pulmonary symptoms and the diagnosis was not made until pathohistological examination.

Entities:  

Mesh:

Year:  2003        PMID: 12727053     DOI: 10.1016/s0899-7071(01)00349-7

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  9 in total

1.  Extrapulmonary uterine lymphangioleiomyomatosis (LAM) and dysfunctional uterine bleeding: the first presentation of LAM in a tuberous sclerosis complex patient.

Authors:  Lucy Grant; Saliya Chipwete; San Soo Hoo; Anjali Bhatnagar
Journal:  BMJ Case Rep       Date:  2019-02-25

2.  Atypical presentation of lymphangioleiomyomatosis as jugular vein thrombosis.

Authors:  Nisar A Wani; T Kosar; T Gojwari
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

3.  Effect of fasting on the size of lymphangioleiomyomas in patients with lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Amanda M Jones; Patricia Julien-Williams; Thomas Shawker; Connie G Glasgow; Mario Stylianou; Joel Moss
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

4.  The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

Authors:  Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

5.  Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus.

Authors:  Angelo M Taveira-DaSilva; Olanda Hathaway; Mario Stylianou; Joel Moss
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

6.  Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going.

Authors:  Angelo M Taveira-Dasilva; Wendy K Steagall; Joel Moss
Journal:  F1000 Med Rep       Date:  2009-12-09

7.  Primary abdominal lymphangioleiomyomatosis: report of a case.

Authors:  Yuan Ding; Sheng Yan; Yang Tian; Zhiwei Li; Jun Pan; Qiyi Zhang; Yan Wang; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2015-03-05       Impact factor: 2.754

Review 8.  Management of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  F1000Prime Rep       Date:  2014-12-01

9.  Lymphangioleiomyomatosis Presenting with Perirenal Hemorrhage.

Authors:  S Dekeyzer; N Peters; P Smeets; P De Visschere; K Decaestecker; R Gosselin
Journal:  J Belg Soc Radiol       Date:  2015-09-15       Impact factor: 1.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.